TXNIP is a potent negative regulator of glucose uptake; in fact, its loss or downregulation is sufficient to increase glucose uptake [19, 39], suggesting that low TXNIP levels may be a common route to aerobic glycolysis common in cancer. The gene discussed is TXNIP; the disease is cancer.